News
News
- Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S.
03/03/2022 / 13:30 - GlobeNewswire - Nirsevimab significantly protected infants against RSV disease in Phase 3 trial
03/03/2022 / 08:00 - GlobeNewswire - MATTHEW J. BRUDERMAN HOSTS RECORD SETTING FUNDRAISER FOR NEW YORK REPUBLICAN GUBERNATORIAL CANDIDATE REP. LEE ZELDIN
03/03/2022 / 00:01 - GlobeNewswire - Enthusiast Gaming and Hut 8 Sign Multi-Year Strategic Partnership
03/02/2022 / 13:00 - GlobeNewswire - Snap One to Host Women in Technology Summit to Celebrate International Women’s Day
03/01/2022 / 22:10 - GlobeNewswire - Deveron Announces Closing of Overnight Marketed Public Offering
02/25/2022 / 15:11 - Newsfile Corp - Myovant Sciences Receives Positive CHMP Opinion for ORGOVYX® (relugolix) for the Treatment of Advanced Prostate Cancer
02/25/2022 / 15:00 - GlobeNewswire - New ACM TechBrief Spotlights Privacy, Ethics Problems with Facial Recognition Technology
02/24/2022 / 16:47 - GlobeNewswire - JAMA Publication Highlights VASCEPA® (Icosapent Ethyl) Cardiovascular Risk Reduction Extends to Cost Effectiveness at Patient Level
02/24/2022 / 13:30 - GlobeNewswire - Cerberus Cyber Sentinel Corporation (Nasdaq: CISO) to Ring The Nasdaq Stock Market Opening Bell
02/23/2022 / 13:45 - GlobeNewswire
Real-time